Intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy occurs in 22% to 47%. Intravesical chemotherapy is still underused due to concerns about its efficacy and ...

Chemotherapy often causes hair loss, but it can depend on the type of chemo drug as well as other factors. An estimated 65% of people undergoing classic chemotherapy experience hair loss, or what ...

The role of intravesical chemotherapy in decreasing tumor recurrence is well established. No consensus has, however, been reached on the best drug schedule, dose, or timing of the instillation.

into your vein - the drugs circulate throughout your body in the bloodstream directly into your tummy (abdomen) during surgery - this is called hyperthermic intraperitoneal chemotherapy (HIPEC) This ...

Intravesical chemotherapy aims to reduce recurrence and progression but may have limited efficacy and potential side effects. PD-L1 inhibitors enhance immune response but can cause immune-related ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.

Risk factors: smoking; certain industrial chemicals. TREATMENT: Tumours removed by surgery, plus 'intravesical therapy': chemotherapy drugs or TB vaccine BCG applied via catheter. For invasive ...

Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new study. A new gold-based ...

The drug has demonstrated an impressive ability to slow tumor growth in animals by 82% while selectively targeting cancer cells far more effectively than traditional chemotherapy agents.